Company Rising BioSciences, Inc.

Equities

RBII

US76761W1080

Entertainment Production

Market Closed - OTC Markets 17:04:29 21/05/2024 BST 5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for Rising BioSciences, Inc. 0.00% 0.00%

Business Summary

Rising Biosciences, Inc. is a research and development company. The Company is focused on oral and topical cannabis and non-cannabis-based pharmaceuticals. The Company operates through three distinct business units. In addition to Oxi Thyme, the second business unit is a physician’s practice management company focused on the proper use of cannabis for the treatment of chronic pain, opioid addiction, and terminal patients. The third business unit is a research and development company focused on oral and topical pharmaceuticals. Through its subsidiaries and investment holdings, the Company is focused on the treatment of individuals in both inpatient and outpatient environments recovering from alcohol and drug addiction.

Sales per Business

USD in Million2019Weight2020Weight Delta
Oral and Topical Cannabis and Non-cannabis Based Pharmaceuticals
100.0 %
0 100.0 % 1 100.0 % +377.77%

Sales per region

USD in Million2019Weight2020Weight Delta
United States
100.0 %
0 100.0 % 1 100.0 % +377.77%

Managers

Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO 75 -
Chief Operating Officer - 07/03/19
Chief Tech/Sci/R&D Officer - -

Members of the board

Members of the board TitleAgeSince
Director of Finance/CFO 75 -
Chief Executive Officer - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 1,059,725,348 1,059,725,348 ( 100.00 %) 0 100.00 %

Company contact information

Rising Biosciences, Inc.

1190 Cleveland Road

44870, Sandusky

+

address Rising BioSciences, Inc.(RBII)
  1. Stock Market
  2. Equities
  3. RBII Stock
  4. Company Rising BioSciences, Inc.